Nanomachines loaded with wine ingredients overcome gene therapy challenges
Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...
Cancer Gene Therapy Market to Surpass Valuation of US$ 17.57 Billion By 2033 | Astute Analytica
International collaborations, refined gene-editing protocols, and targeted immunologic maneuvers keep the cancer gene therapy ...
Gene therapies have been uneven for DMD — but these companies hope to turn the tide
Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the belief the answer could come down to delivery.
ALS News Today2d
AMT-162 gene therapy trial for SOD1-ALS set for next dose group
Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...
GlobalData on MSN15d
Viralgen and Axovia to develop gene therapy for retinal dystrophy
Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal ...
ophthalmologytimes5d
Gene therapy voretigene neparvovec boosts vision in pediatric IRD patients
Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...
Managed Healthcare Executive7d
Gene Therapy’s Pipeline Has a Steady Flow of More Than 2,000 Candidates
The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...